Menopur Mixed Protocol
Completed · Phase 4
Conditions studied: Infertility
In brief
The objective of this study was to compare the fertilization rate between the combination of Menopur and Bravelle mixed in the same syringe and Menopur alone, both administered subcutaneously (SC), in subjects undergoing Assisted Reproductive Technology (ART). Additionally the study assessed subjects' ability to mix and store the combination of Menopur and Bravelle and to assess safety of the Menopur and Bravelle combination.
Key facts
- Study ID
- NCT01417195
- Run by
- Ferring Pharmaceuticals
- People needed
- 122
- Starts
- 2011-07-01
- Expected to finish
- 2012-01-01
- Last updated by the study team
- 2014-05-16
Who can join
Age: 18 and older, up to 42. Sex: female. Healthy volunteers: not accepted.
Where it is running
- Colorado Center for Reproductive Medicine — Lone Tree, Colorado, United States
- Women's Medical Research Group — Clearwater, Florida, United States
- Reproductive Biology Associates — Atlanta, Georgia, United States
- Fertility Center of Illinois — Chicago, Illinois, United States
- The Advanced IVF Institute — Naperville, Illinois, United States
- Shady Grove Fertility — Rockville, Maryland, United States
- The Center for Assisted Reproduction — Bedford, Texas, United States
- Houston Fertility Institute — Houston, Texas, United States
- Center of Reproductive Medicine — Webster, Texas, United States
- Seattle Reproductive Medicine — Seattle, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.